Not Tagged
Not Tagged
['breast', 'paradigm']
cdk2 inhibitors have established biological rationale and early signs of clinical activity presented earlier this weekend at #asco23. excited to see where cdk2 inhibitors might fit into the treatment paradigm for breast and other tumor types. 
34 y/o G2P2 presents w/ insatiable thirst for knowledge of unknown etiology | @RiceUniversity @UTSWNews alum | Associate Medical Director @DAVAOnc